News & Perspective

Dec 19, 2008

Dec 19, 2008

With H1N1 resistance, CDC changes advice on flu drugs

(CIDRAP News) – Increased resistance to oseltamivir (Tamiflu), the leading influenza drug, has prompted federal health officials to change their advice about flu treatment, saying clinicians for now should consider using zanamivir (Relenza) or a combination of two drugs for patients suspected of having influenza A.

Dec 01, 2008

Dec 01, 2008

PROMISING PRACTICES FOR PANDEMIC PLANNING Addressing psychological needs in disaster response

Editor's Note: CIDRAP's Public Health Practices online database showcases peer-reviewed practices, including useful tools to help others with their planning. This article is one of a series exploring the development of these practices. We hope that describing the process and context of these practices enhances pandemic planning.

Jul 31, 2008

Jul 31, 2008

State models cited as ways to improve outbreak responses

(CIDRAP News) – Experts and industry leaders speaking at congressional hearings this week on the nationwide Salmonella outbreak said federal agencies should take cues from state programs if they want to improve the traceability of fresh produce and the success of foodborne disease outbreak investigations.

Jul 24, 2008

Jul 24, 2008

Minnesota tactics helped reveal Salmonella source

(CIDRAP News) – New details emerged today about breaks in the Salmonella investigation that led to the identification of the outbreak strain in a jalapeno pepper, as the number of cases in the nationwide outbreak rose to 1,284.

Mar 07, 2008

Mar 07, 2008

CDC retires one old smallpox vaccine, keeps another

(CIDRAP News) – Federal health officials recently announced plans to get rid of their last remaining stocks of the decades-old smallpox vaccine Dryvax, as a newer vaccine takes its place in the national stockpile of emergency medical supplies.

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»